Employing the immunological synapse in AML: Development of leukemic dendritic cells for active specific immunization
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Immunobiology
- Vol. 210 (2-4) , 249-257
- https://doi.org/10.1016/j.imbio.2005.05.019
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Quantification of T‐cell–mediated apoptosis in heterogeneous leukemia populations using four‐color multiparameter flow cytometryCytometry Part A, 2005
- Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacityLeukemia, 2005
- Dendritic-cell-based therapeutic vaccination against cancerCurrent Opinion in Immunology, 2005
- Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivoBlood, 2004
- Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cellsLeukemia, 2003
- CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cellsBlood, 2002
- Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function – implications for the adoptive immunotherapy of leukaemiaClinical and Experimental Immunology, 2001
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Protective and Therapeutic Immunity Against Leukemia Induced by Irradiated B7-1 (CD80)-Transduced Leukemic CellsHuman Gene Therapy, 1997